نتائج البحث

Ramucirumab in second‑line advanced colorectal cancer therapy: A study on therapeutic outcomes and hepatic sinusoidal platelet aggregation.

• Authors : Kimura K; Department of Gastroenterological Surgery, Okayama University Hospital, Okayama 700-8558, Japan.; Katata Y

• Source: Oncology letters [Oncol Lett] 2024 Jul 15; Vol. 28 (3), pp. 439. Date of Electronic Publication: 2024 Jul 15 (Print Publication: 2024).Publisher: Spandidos Publications] Country of Publication: Greece NLM ID: 101531236 Publication Model: eCollection Cited Medium: Internet ISSN:

تفاصيل العنوان

Irinotecan plus raltitrexed as second‑line chemotherapy for metastatic colorectal cancer: A retrospective study.

• Authors : Lian J; Department of Outpatient Chemotherapy, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150040, P.R. China.; Wang R

• Source: Oncology letters [Oncol Lett] 2024 Jun 28; Vol. 28 (3), pp. 409. Date of Electronic Publication: 2024 Jun 28 (Print Publication: 2024).Publisher: Spandidos Publications] Country of Publication: Greece NLM ID: 101531236 Publication Model: eCollection Cited Medium: Internet ISSN:

تفاصيل العنوان

Regorafenib plus programmed death‑1 inhibitors vs. regorafenib monotherapy in second‑line treatment for advanced hepatocellular carcinoma: A systematic review and meta‑analysis.

• Authors : Li Z; Department of Hepato-Biliary-Pancreas II, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan 637000, P.R. China.; Wang J

• Source: Oncology letters [Oncol Lett] 2024 May 14; Vol. 28 (1), pp. 318. Date of Electronic Publication: 2024 May 14 (Print Publication: 2024).Publisher: Spandidos Publications] Country of Publication: Greece NLM ID: 101531236 Publication Model: eCollection Cited Medium: Internet ISSN:

تفاصيل العنوان

A multicenter single-arm Phase II clinical trial of second-line FOLFIRI plus panitumumab after first-line treatment with FOLFOX plus panitumumab for initial RAS wild-type colorectal cancer with evaluation of circulating tumor DNA: A protocol study.

• Authors : Maeda, Hiromichi (AUTHOR) ; Nagata, Naoki (AUTHOR); Nagasaka, Takeshi (AUTHOR)

• Source: Oncology Letters. Feb2019, Vol. 17 Issue 2, p1980-1985. 6p.

تفاصيل العنوان

Pretreatment fibrinogen levels are associated with survival outcome in patients with cancer using immunotherapy as a second‑line treatment.

• Authors : Xu R; Department of Oncology, Hainan Hospital of People's Liberation Army General Hospital, Sanya, Hainan 572013, P.R. China.; Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China.

• Source: Oncology letters [Oncol Lett] 2023 May 05; Vol. 25 (6), pp. 269. Date of Electronic Publication: 2023 May 05 (Print Publication: 2023).Publisher: Spandidos Publications] Country of Publication: Greece NLM ID: 101531236 Publication Model: eCollection Cited Medium: Internet ISSN:

تفاصيل العنوان

Efficacy of second-line treatment and importance of comorbidity scores and clinical parameters affecting prognosis in elderly patients with non-small cell lung cancer without epidermal growth factor receptor mutations.

• Authors : Lee, Sung Yong¹; Kang, Eun Joo² ; Lee, Suk Young²

• Source: Oncology Letters. Jan2018, Vol. 15 Issue 1, p600-609. 10p.

تفاصيل العنوان

Use of gemcitabine as a second-line treatment following chemotherapy with folfirinox for metastatic pancreatic adenocarcinoma.

• Authors : SARABI, MATTHIEU¹ ; MAIS, LAETITIA¹; OUSSAID, NADIA²

• Source: Oncology Letters. Jun2017, Vol. 13 Issue 6, p4917-4924. 8p.

تفاصيل العنوان

Pretreatment fibrinogen levels are associated with survival outcome in patients with cancer using immunotherapy as a second‑line treatment

• Authors : Rui Xu; Tao Yang; Bing Yan

Subjects: Cancer Research; Oncology

• Source: Oncology Letters. 25

تفاصيل العنوان

Role of free testosterone levels in patients with metastatic castration-resistant prostate cancer receiving second-line therapy.

• Authors : VON KLOT, CHRISTOPH A.¹; KUCZYK, MARKUS A.¹; BOEKER, ALENA¹

• Source: Oncology Letters. Jan2017, Vol. 13 Issue 1, p22-28. 7p.

تفاصيل العنوان

Establishment of a first-line second-line treatment model for human pulmonary adenocarcinoma.

• Authors : LINING WANG¹ ; YU WANG²; QI GUAN¹

• Source: Oncology Letters. Dec2016, Vol. 12 Issue 6, p4461-4466. 6p.

تفاصيل العنوان